Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

Next Generation Vector Vortex Waveplates for Astronomical Coronagraphs

Active
NASA-SBIR-154414SBIR / STTR

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

National Aeronautics and Space Administration → NASA SBIR/STTR ProgramView Agency

Contract Value

$850,000

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)View NAICS

Place of Performance

Pasadena, CA, 91109, USA

Set-Aside

SBA

Awardee

Jet Propulsion LaboratoryView Profile

Award Issued Date

Documents

(1)

S12.01-2830 Next generation vector vortex waveplates for astronomical coronagraphs

PDFbriefing-chart

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseSolicitation
Posted

Solicitation

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyNational Aeronautics and Space Administration → NASA SBIR/STTR Program
Contacts4 people available
OfficeUSA
Organization / Agency
National Aeronautics and Space Administration → NASA SBIR/STTR Program
View Agency Profile
Office AddressUSA
Contacts
Lynn M TorresProject Manager
Nelson TabirianPrincipal Investigator
Jason L KesslerProgram Director
Carlos TorrezProgram Manager

Interested Companies (2)

Show more
Jet Propulsion Laboratory
Pasadena, CA

Full Description

Show more
Vector vortex waveplates (VVWs) are highly promising technology enabling astronomical coronagraph masks for exoplanet imaging and characterization. Currently, the technology basics are well known, and there have been successful demonstrations of VVWs meeting several key operational requirements. The next generation of VVWs under development will make it possible to extend their spectral range of performance into infrared, further increase the contrast using novel materials, and would improve manufacturing to reduce cost. Yield and quality will be increased by eliminating internal and external sources of structural non-uniformities and defects and by employing novel minimally invasive manufacturing processes. Novel designs and device architectures to be developed in the Phase 2 of the project are intended to improve performance of VVWs to the levels that would not require polarization filtering thus increasing the throughput nearly twice. High contrast liquid crystal polymer broadband reflective VVWs to be developed wherein geometrical phase is insensitive to retardation would allow novel coronagraph architectures while minimizing dependence on process conditions and simplifying manufacturing. Furthermore, the next generation VVWs would allow reducing size and weight of coronagraphs by integrating VVW technology with other planar optics functions. The next generation of VVWs under development will make it possible to extend their spectral range of performance into infrared, further increase the contrast using novel materials, and would improve manufacturing to reduce cost. Yield and quality will be increased by eliminating internal and external sources of structural non-uniformities and defects and by employing novel non-invasive manufacturing processes. Novel designs and device architectures to be developed in the Phase 2 of the project are intended to improve performance of VVWs to the levels that would not require polarization filtering thus increasing the throughput nearly twice. High contrast liquid crystal polymer broadband reflective VVWs to be developed wherein geometrical phase is insensitive to retardation would allow novel coronagraph architectures while minimizing dependence on process conditions. The next generation VVWs would allow reducing size and weight of coronagraphs by integrating VVW technology with other optical functions. The Phase 2 of the project would allow overcoming the problems we are still facing in the fabrication of VVWs for advancing the technology into coronagraph applications and to the next generation characterized by: ultrahigh contrast; ultralow-scatter and defects; ultrabroadband spectra of high diffraction efficiency; spectra extended to SWIR-MWIR; polarization-independence; availability of transmissive as well as reflective systems; feasibility of combining multiple functions into a single thin film, and, making VVWs with higher yield and lower cost by developing robust VVW architectures that would eliminate or, at least, will dramatically reduce the effects of fabrication errors and ambient conditions on device performance. Meeting these objectives in the Phase 2 would require maturation of the breakthroughs in fabrication technology, some of them demonstrated in the Phase 1 of the project: direct assembly minimizing or fully avoiding release/transfer processes; fabrication VVWs on ultrathin glass; tuning retardation during and post-polymerization; enhancing automation level to ensure absence of defects and high quality for multiple coatings required for ultrabroadband and SWIR components; and, necessarily, ability to perform more of the key fabrication and test processes in higher purity and environmentally stabilized clean room.
Benefits: Astronomical coronagraphs, optical communications; quantum computing; super-resolution imaging Free-space optical communication; optical tweezers and micromanipulation; bio-sensors; quantum computing; image processing; Shaping of high power laser beams

Similar Contracts

Same NAICS industry code

NAICS: 541715
New
Federal
Regulatory Science Tool for Transcranial Ultrasound Modeling
Solicitation # 75F40126Q00351
The FDA's Center for Devices and Radiological Health is seeking a contractor under solicitation 75F40126Q00351 to develop a Regulatory Science Tool for transcranial ultrasound modeling. The objective is to create a computational modeling package to simulate sonication protocols, standardize modeling techniques, and establish consensus on acoustic and thermal tissue properties to support regulatory review and patient safety. The project involves performing validation using shared measurement datasets, conducting sensitivity analysis, and developing baseline, best-case, and worst-case patient models. The contractor may utilize a single-technique or dual-technique approach using Finite Difference Time Domain or Pseudo-Spectral Time Domain methods, leveraging open-source toolsets such as k-Wave and BabelViscoFDTD. This firm fixed price contract has a performance period of twelve months from the date of award. The final software package must be modular, version-controlled, and compatible with Windows, Linux, and macOS. To be eligible, the contractor's principal or co-investigator must have completed at least two research projects involving transcranial ultrasound simulation within the last five years or have contributed significantly to relevant open-source tools. Award will be based on technical acceptability and a fair and reasonable price. The contractor must adhere to strict cybersecurity requirements, including the handling of Controlled Unclassified Information and the reporting of security incidents to the FDA Cybersecurity and Infrastructure Operations Coordination Center within one hour of discovery.
FDA Office Of Acq Grant Svcs

POSTED

about 12 hours ago

DEADLINE

in 5 days
View Details
NAICS: 541715
New
Federal
ARMY OPEN SOLICITATION (AOS)
Solicitation # W9128Z-25-S-A002
The Army Open Solicitation (AOS), identified by solicitation number W9128Z-25-S-A002, is an indefinite, open solicitation issued by the U.S. Army Contracting Command – Aberdeen Proving Ground to rapidly acquire innovative commercial technologies and research-driven solutions across all Army mission areas. Designed to revitalizing the industrial base and enhancing Warfighter lethality, the solicitation leverages a flexible acquisition framework under multiple FAR, DFARS, and U.S. Code authorities, including Other Transactions, Commercial Solutions Opening, and prototype authorities. It supports both Active Capability Gap submissions and periodic Calls for Solutions, with responses evaluated based on technical merit, feasibility, schedule, price estimation, viability, and desirability using a trade-off approach rather than lowest price technically acceptable. The solicitation remains open indefinitely until canceled, with recent amendments through March 2026 expanding and clarifying Army Example Areas, refining submission procedures, and updating contracting information including Active Capability Gap mailboxes. All submissions must adhere to strict formatting requirements, including a single PDF submission not exceeding five pages or fifteen slides, with mandatory inclusion of an executive summary, company information, and rough order of magnitude cost and schedule estimates. Offerors must be registered in SAM, use WAWF for invoicing, and comply with stringent data storage and security requirements, including U.S.-only data hosting and full organizational conflict of interest disclosures. The solicitation encourages participation from small businesses, nontraditional defense contractors, and nonprofit research institutions, with specific certifications required through the Affirmation of Business Status Certification. Performance may occur at government facilities including Aberdeen Proving Ground and other CONUS/OCONUS locations as directed, with award timing anticipated in fiscal year 2026, and support expected through 2032. No fixed contract value is provided, as pricing is determined through competitive evaluation of commercial proposals under the solicitation's open-ended structure.
W6QK Acc-Apg Contr Ctr

POSTED

about 12 hours ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Federal
Market forecast analyses for West Nile virus (WNV) vaccine and anti-WNV monoclonal antibody for prophylaxis
Solicitation # 97469
The Centers for Disease Control and Prevention (CDC), through the National Center for Emerging and Zoonotic Infectious Diseases, is soliciting quotations for Request for Quotation (RFQ) No. 75D301-26-Q-79208. The objective is to acquire two comprehensive market forecast analyses focusing on a human West Nile virus (WNV) vaccine and an anti-WNV monoclonal antibody for seasonal pre-exposure prophylaxis. This acquisition will be awarded as a Time-and-Materials (T&M) purchase order with a 12-month period of performance from September 30, 2026, to September 29, 2027. The scope of work includes epidemiologic data synthesis, health economic modeling, stakeholder engagement via structured interviews, and the preparation of peer-reviewed publications to disseminate findings to the scientific community. The award will be based on the best-value procurement process, where technical approach, management approach, organizational experience, and past performance are significantly more important than price. Technical evaluation will focus on the contractor's ability to develop transparent forecasting models and integrate complex clinical, commercial, and policy data. Required labor categories for the T&M contract include a Principal Investigator, Postdoctoral Fellow, Health Economist, and Research Analyst. Offerors must provide a completed pricing schedule, written acknowledgement of the Statement of Work, and proof of active SAM registration. All quotes must be submitted to the contracting specialist by September 2, 2026, at 10:00 AM EST.
CDC Office Of Acquisition Services

POSTED

about 12 hours ago

DEADLINE

in 7 days
View Details

More opportunities from National Aeronautics and Space Administration → NASA SBIR/STTR Program

Same awarding agency